Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Seckinger

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Oncotarget|February 12, 2015
Drug metabolism and clearance system in tumor cells of patients with multiple myelomaWafa Hassen, Alboukadel Kassambara, Thierry Reme, et al.
International Journal of Molecular Sciences|April 12, 2022
Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic ScaleFelix Jenne, Sergey Biniaminov, Nathalie Biniaminov, et al.
Haematologica|March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysisMartin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
Tissue Engineering|May 24, 2007
Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitroPhilipp Niemeyer, Martin Kornacker, Alexander Mehlhorn, et al.
Experimental Hematology|February 15, 2011
Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environmentCaroline Bret, Dirk Hose, Thierry Reme, et al.
Cell Transplantation|March 25, 2020
Quantitative Efficacy and Fate of Mesenchymal Stromal Cells Targeted to Cardiac Sites by Radiofrequency Catheter AblationRizwan Malik, Fabrice A Darche, Rasmus Rivinius, et al.
Oncotarget|December 13, 2017
<i>CD24</i>, <i>CD27</i>, <i>CD36</i> and <i>CD302</i> gene expression for outcome prediction in patients with multiple myelomaElina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, et al.
Cytometry. Part B, Clinical Cytometry|November 13, 2018
BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myelomaGuilhem Requirand, Nicolas Robert, Stéphanie Boireau, et al.
Cancer|April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasoneUlrike Klein, Anna Jauch, Thomas Hielscher, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Oncotarget|February 12, 2015
Drug metabolism and clearance system in tumor cells of patients with multiple myelomaWafa Hassen, Alboukadel Kassambara, Thierry Reme, et al.
International Journal of Molecular Sciences|April 12, 2022
Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic ScaleFelix Jenne, Sergey Biniaminov, Nathalie Biniaminov, et al.
Haematologica|March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysisMartin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
Tissue Engineering|May 24, 2007
Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitroPhilipp Niemeyer, Martin Kornacker, Alexander Mehlhorn, et al.
Experimental Hematology|February 15, 2011
Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environmentCaroline Bret, Dirk Hose, Thierry Reme, et al.
Cell Transplantation|March 25, 2020
Quantitative Efficacy and Fate of Mesenchymal Stromal Cells Targeted to Cardiac Sites by Radiofrequency Catheter AblationRizwan Malik, Fabrice A Darche, Rasmus Rivinius, et al.
Oncotarget|December 13, 2017
<i>CD24</i>, <i>CD27</i>, <i>CD36</i> and <i>CD302</i> gene expression for outcome prediction in patients with multiple myelomaElina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, et al.
Cytometry. Part B, Clinical Cytometry|November 13, 2018
BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myelomaGuilhem Requirand, Nicolas Robert, Stéphanie Boireau, et al.
Cancer|April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasoneUlrike Klein, Anna Jauch, Thomas Hielscher, et al.
Pageof 13